Loading...
•
Dec 31, 2023
CryoPort Q4 2023 Earnings Report
Reported financial results for the fourth quarter and full year 2023.
Key Takeaways
Cryoport reported full year revenue of $233.3 million. The services business increased to 62% of total revenue, with year-over-year growth in BioStorage/BioServices and support of commercial Cell & Gene therapies of 45% and 33%, respectively. The company supported a record 675 clinical trials worldwide.
Total revenue for FY 2023 was $233.3 million.
Services business increased to 62% of total revenue.
Revenues from BioStorage/BioServices grew 45% year-over-year.
Supported 675 global clinical trials, a net increase of 21 clinical trials over the prior year.
CryoPort
CryoPort
CryoPort Revenue by Segment
Revenue by Segment
Life Sciences Services Revenue
CapyFin.comLife Sciences Products Revenue
CapyFin.com Forward Guidance
The Company is expecting revenue to grow progressively and is providing full year 2024 revenue guidance of $242 - $252 million.
Revenue & Expenses
Visualization of income flow from segment revenue to net income